These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35125809)

  • 1. Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations.
    Zhou R; Zheng H; Liu M; Liu Z; Guo C; Tian H; Liu F; Liu Y; Pan Y; Chen H; Hu Z; Cai H; He Z; Ke Y
    Chin J Cancer Res; 2021 Dec; 33(6):649-658. PubMed ID: 35125809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and external validation of a quantitative diagnostic model for malignant gastric lesions in clinical opportunistic screening: A multicenter real-world study.
    Zheng H; Liu Z; Chen Y; Ji P; Fang Z; He Y; Guo C; Xiao P; Wang C; Yin W; Li F; Chen X; Liu M; Pan Y; Liu F; Liu Y; He Z; Ke Y
    Chin Med J (Engl); 2024 Feb; ():. PubMed ID: 38403900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, validation, and evaluation of a risk assessment tool for personalized screening of gastric cancer in Chinese populations.
    Zhu X; Lv J; Zhu M; Yan C; Deng B; Yu C; Guo Y; Ni J; She Q; Wang T; Wang J; Jiang Y; Chen J; Hang D; Song C; Gao X; Wu J; Dai J; Ma H; Yang L; Chen Y; Song M; Wei Q; Chen Z; Hu Z; Shen H; Ding Y; Li L; Jin G
    BMC Med; 2023 Apr; 21(1):159. PubMed ID: 37106459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a novel scoring system for gastric cancer opportunistic screening in hospital visits.
    Zhou Q; Chen Y; Pan J; Zhou L; Lin J
    BMC Gastroenterol; 2022 May; 22(1):223. PubMed ID: 35527297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China.
    Liu M; Liu Z; Cai H; Guo C; Li X; Zhang C; Wang H; Hang D; Liu F; Deng Q; Yang X; Yuan W; Pan Y; Li J; Zhang C; Shen N; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1538-1546.e7. PubMed ID: 28342951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applicability of a new scoring system for population-based screening and risk factors of gastric cancer in the Wannan region.
    Li L; Ni J; Sun S; Zha X; Li R; He C
    BMC Gastroenterol; 2022 Jun; 22(1):306. PubMed ID: 35739473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic Health Record-Based Absolute Risk Prediction Model for Esophageal Cancer in the Chinese Population: Model Development and External Validation.
    Han Y; Zhu X; Hu Y; Yu C; Guo Y; Hang D; Pang Y; Pei P; Ma H; Sun D; Yang L; Chen Y; Du H; Yu M; Chen J; Chen Z; Huo D; Jin G; Lv J; Hu Z; Shen H; Li L
    JMIR Public Health Surveill; 2023 Mar; 9():e43725. PubMed ID: 36781293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and External Validation of an Improved Version of the Diagnostic Model for Opportunistic Screening of Malignant Esophageal Lesions.
    Liu Z; Zheng H; Liu M; He Y; Chen Y; Ji P; Fang Z; Xiao P; Li F; Guo C; Yin W; Pan Y; He Z; Ke Y
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study.
    Cai Q; Zhu C; Yuan Y; Feng Q; Feng Y; Hao Y; Li J; Zhang K; Ye G; Ye L; Lv N; Zhang S; Liu C; Li M; Liu Q; Li R; Pan J; Yang X; Zhu X; Li Y; Lao B; Ling A; Chen H; Li X; Xu P; Zhou J; Liu B; Du Z; Du Y; Li Z;
    Gut; 2019 Sep; 68(9):1576-1587. PubMed ID: 30926654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study.
    Zhu J; Wang L; Gong W; Li X; Wang Y; Zhu C; Li H; Shi L; Yang C; Du L
    Cancer; 2024 Apr; 130(S8):1403-1414. PubMed ID: 37916832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Screening Questionnaire of COPD from a Large Epidemiological Study in China.
    Wang D; Fan G; Wu S; Yang T; Xu J; Yang L; Zhao J; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Chen Y; Sun T; Shan G; Lin Y; Xu G; Wang R; Shi Z; Xu Y; Ye X; Song Y; Wang Q; Zhou Y; Li W; Ding L; Wan C; Yao W; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Wang Z; Bu X; Zhang H; Zhang X; An L; Zhang S; Zhu J; Cao Z; Zhan Q; Yang Y; Liang L; Dai H; Cao B; He J; Wang C;
    COPD; 2022; 19(1):118-124. PubMed ID: 35385369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 14. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
    Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
    EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction algorithm for gastric cancer in a general population: A validation study.
    Wong MCS; Leung EY; Yau STY; Chan SC; Xie S; Xu W; Huang J
    Cancer Med; 2023 Nov; 12(21):20544-20553. PubMed ID: 37855240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved risk scoring systems for colorectal cancer screening in Shanghai, China.
    Wu WM; Gu K; Yang YH; Bao PP; Gong YM; Shi Y; Xu WH; Fu C
    Cancer Med; 2022 May; 11(9):1972-1983. PubMed ID: 35274820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of different serological methods in screening early gastric cancer].
    Ni DQ; Lyu B; Bao HB; Jin HF; Zhao J; Xu Y; Huang X
    Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):294-300. PubMed ID: 30917423
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer.
    Huang S; Guo Y; Li ZW; Shui G; Tian H; Li BW; Kadeerhan G; Li ZX; Li X; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
    JAMA Netw Open; 2021 Jun; 4(6):e2114186. PubMed ID: 34156450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.
    Tao S; Hoffmeister M; Brenner H
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):478-85. PubMed ID: 24022090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.